These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21484378)

  • 1. Molecular imaging in patients with mood disorders: a review of PET findings.
    Chen Q; Liu W; Li H; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1367-80. PubMed ID: 21484378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of positron emission tomography in psychiatry.
    Parsey RV; Mann JJ
    Semin Nucl Med; 2003 Apr; 33(2):129-35. PubMed ID: 12756645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood disorders.
    Yurgelun-Todd DA; Sava S; Dahlgren MK
    Neuroimaging Clin N Am; 2007 Nov; 17(4):511-21, ix. PubMed ID: 17983967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroreceptor imaging of stress and mood disorders.
    Kennedy SE; Zubieta JK
    CNS Spectr; 2004 Apr; 9(4):292-301. PubMed ID: 15048054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Phenotypes Detectable with PET in Mood Disorders: Elevated Monoamine Oxidase A and Translocator Protein Level.
    Meyer J
    PET Clin; 2017 Jul; 12(3):361-371. PubMed ID: 28576173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
    Marshall GA; Monserratt L; Harwood D; Mandelkern M; Cummings JL; Sultzer DL
    Arch Neurol; 2007 Jul; 64(7):1015-20. PubMed ID: 17620493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of positron emission tomography in psychiatry].
    Degrell I; Berecz R; Glaub T; Lengyel Z; Egerházi A; Szakáll S; Trón L
    Orv Hetil; 2002 May; 143(21 Suppl 3):1311-4. PubMed ID: 12077925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652.
    Ichimiya T; Suhara T; Sudo Y; Okubo Y; Nakayama K; Nankai M; Inoue M; Yasuno F; Takano A; Maeda J; Shibuya H
    Biol Psychiatry; 2002 May; 51(9):715-22. PubMed ID: 11983185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in pursuit of neurobiology: strengths, limitations, and the quest for new paradigms in depression and mood.
    Kumar A
    Am J Geriatr Psychiatry; 2000; 8(4):284-8. PubMed ID: 11069267
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states.
    Hosokawa T; Momose T; Kasai K
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):243-50. PubMed ID: 19100808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of the 5-HT(1A) receptor in relation to human cognition.
    Borg J
    Behav Brain Res; 2008 Dec; 195(1):103-11. PubMed ID: 18606193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience.
    Kumar A; Ajilore O; Kepe V; Barrio JR; Small G
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):555-63. PubMed ID: 18044797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography in neuropsychiatry.
    Faulstich ME; Sullivan DC
    Invest Radiol; 1991 Feb; 26(2):184-94. PubMed ID: 2055721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers.
    Andries J; Lemoine L; Le Bars D; Zimmer L; Billard T
    Eur J Med Chem; 2011 Aug; 46(8):3455-61. PubMed ID: 21620533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhuman primate positron emission tomography neuroimaging in drug abuse research.
    Howell LL; Murnane KS
    J Pharmacol Exp Ther; 2011 May; 337(2):324-34. PubMed ID: 21317354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological challenge strategies: implications for neurochemical mechanisms in affective disorders and treatment approaches.
    Risch SC; Kalin NH; Murphy DL
    J Clin Psychopharmacol; 1981 Jul; 1(4):238-43. PubMed ID: 6117587
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropsychiatric aspects of hypothyroidism and treatment reversibility.
    Davis JD; Tremont G
    Minerva Endocrinol; 2007 Mar; 32(1):49-65. PubMed ID: 17353866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography in psychiatric disorders.
    Newberg AB; Moss AS; Monti DA; Alavi A
    Ann N Y Acad Sci; 2011 Jun; 1228():E13-25. PubMed ID: 22239386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding.
    Frokjaer VG; Vinberg M; Erritzoe D; Svarer C; Baaré W; Budtz-Joergensen E; Madsen K; Madsen J; Kessing LV; Knudsen GM
    Neuroimage; 2009 Jun; 46(2):360-6. PubMed ID: 19233297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.
    Erritzoe D; Talbot P; Frankle WG; Abi-Dargham A
    Neuroimaging Clin N Am; 2003 Nov; 13(4):817-32. PubMed ID: 15024964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.